Article

Single-use IOL implantation system is safe and sterile

A preloaded single-use IOL implantation system (Advanced Medical Optics) currently in development seems to be easier for surgeons to learn to use compared with the current system for implanting acrylic IOLs.

Key Points

The components of the system are made of a lightweight polymer material; the system has a cartridge that contains a preloaded IOL, he explained.

"The device is fully disposable, the IOL is preloaded, and the delivery of the lens into the eye is completely planar even with three-piece, haptic-type IOLs," said Dr. Steinert, vice chairman of clinical ophthalmology, director of refractive, cornea and cataract surgery, and professor of ophthalmology and professor of biomedical engineering, University of California Irvine, Irvine. "The device can be advanced either with a plunge or with a twist screw mechanism. The device is inserted through a 2.8-mm incision."

The IOL has a haptic made of polyimide, which is a tougher material than polymethylmethacrylate when using this new type of injector.

"This material is particularly useful because there is no worry about damaging a kinking haptic," he said.

"My clinical impression after having used this system in the laboratory is that the preparation is very straightforward, it is comfortable to hold, and provides ease of surgical use, and it is disposable. There is no contact with the implant during the preparation," Dr. Steinert continued.

"These features, therefore, afford several advantages. The loading is extremely reliable and because there is no contact with the IOL the sources of sterile and infectious endophthalmitis are reduced. Removing any contact of the implant with the external environment is critical," he concluded.

This implantation system is in the prerelease phase in Europe and will be available later in the United States.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.